Surmounting structural barriers to tackle endemic infectious diseases.

TitleSurmounting structural barriers to tackle endemic infectious diseases.
Publication TypeJournal Article
Year of Publication2021
AuthorsCalderón F, Fairlamb AH, Strange M, Williams P, Nathan CF
JournalJ Exp Med
Volume218
Issue9
Date Published2021 Sep 06
ISSN1540-9538
KeywordsAcademies and Institutes, Communicable Diseases, Drug Development, Drug Industry, Endemic Diseases, Humans, Public-Private Sector Partnerships
Abstract

A unique experiment in bringing academic and industrial scientists together to tackle endemic infectious diseases has proved a success. The Tres Cantos Open Lab Foundation, guided and advised by independent experts, funds extended stays of academics at the campus of a pharmaceutical company, where they access the firm's resources in partnership with company scientists. Progress in tackling tuberculosis, protozoal infections, and enteric bacterial diseases has sustained the decade-long evolution of the model, whose distinctive features complement other public-private partnerships with similar goals.

DOI10.1084/jem.20211418
Alternate JournalJ Exp Med
PubMed ID34410327
PubMed Central IDPMC8383816

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587